An updated synthesis of [11 C]carfentanil for positron emission tomography (PET) imaging of the μ-opioid receptor.
Joseph E BlechaBradford D HendersonBrian G HockleyHenry F VanBrocklinJon-Kar ZubietaAlexandre F DaSilvaMichael R KilbournRobert A KoeppePeter J H ScottXia ShaoPublished in: Journal of labelled compounds & radiopharmaceuticals (2017)
[11 C]Carfentanil ([11 C]CFN) is a selective radiotracer for in vivo positron emission tomography imaging studies of the μ-opioid system that, in our laboratories, is synthesized by methylation of the corresponding carboxylate precursor with [11 C]MeOTf, and purified using a C2 solid-phase extraction cartridge. Changes in the commercial availability of common C2 cartridges have necessitated future proofing the synthesis of [11 C]CFN to maintain reliable delivery of the radiotracer for clinical imaging studies. An updated synthesis of [11 C]CFN is reported that replaces a now obsolete purification cartridge with a new commercially available version and also substitutes the organic solvents used in traditional production methods with ethanol.
Keyphrases
- pet imaging
- positron emission tomography
- computed tomography
- solid phase extraction
- high resolution
- chronic pain
- pain management
- pet ct
- liquid chromatography tandem mass spectrometry
- molecularly imprinted
- high performance liquid chromatography
- case control
- simultaneous determination
- liquid chromatography
- mass spectrometry
- water soluble
- binding protein
- high resolution mass spectrometry